Thomas H Silberg, Senior Healthcare Advisor – Tom is a seasoned professional in the Pharmaceutical and Biopharmaceutical Industries with substantial executive level experience, including major branded pharmaceuticals, medium-sized biotech, start-up biotech, and generic IV drug manufacturing. Tom has recently retired as CEO and Director of Stemprotein, LLC. A San Diego startup company that produces bioactive stem cell proteins and is currently serving as a senior executive consultant. His most recent experience has been as President and CEO of Genway Biotech, Inc., a custom lab/diagnostic business in San Diego. Previously he was President and CEO of APP North America, a wholly owned subsidiary of Fresenius Kabi, a global healthcare company based in Germany. Prior to the Fresenius acquisition of APP, he served as President and CEO of APP Pharmaceuticals. He has also held COO positions for Tercica, Inc. and Ligand Pharmaceuticals Inc.